Status:

TERMINATED

Role of Topical Tranexamic Acid in Total Hip Arthroplasty

Lead Sponsor:

Northwell Health

Conditions:

Post Operative Blood Loss

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

Total hip arthroplasty (THA) is a procedure associated with perioperative blood loss, requiring blood transfusions in some patients. The major cause of this blood loss is due to surgical trauma that i...

Eligibility Criteria

Inclusion

  • 18-80 years of age.
  • Male or female.
  • Degenerative joint disease of hip joint.
  • Primary uncemented total hip arthroplasty.
  • Willingness to participate in the study, follow up at regular intervals

Exclusion

  • Known allergy to tranexamic acid
  • History of any acquired disturbances of color vision
  • Preoperative anemia on basis of pre-operative lab work up (a hemoglobin value of \<11 g/dL in females and \<12 g/dL in males)
  • History of previous myocardial infarction
  • History of arterial or venous thromboembolic disease
  • History of fibrinolytic disorders requiring intraoperative antifibrinolytic treatment, coagulopathy in the past and/or as identified by a preoperative platelet count of \<150,000/mm3, an international normalized ratio of \>1.5, or a prolonged partial thromboplastin time
  • Pregnancy (h/o any missed menstrual periods in a women of reproductive age group)
  • Breastfeeding
  • Refusal of blood products
  • Preoperative use of anticoagulant therapy within five days before surgery
  • Medical issues that may pose complications for surgery and would disqualify patient for surgery regardless of clinical trial (e.g. renal and hepatic failure)
  • Major comorbidities (e.g. severe ischemic heart disease )
  • Severe pulmonary disease
  • Preoperative blood donation
  • Participation in another clinical trial involving pharmaceutical drugs

Key Trial Info

Start Date :

November 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2016

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT01866943

Start Date

November 1 2011

End Date

October 1 2016

Last Update

March 13 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

North Shore Long Island Jewish Lenox Hill Hospital

New York, New York, United States, 10075